does tirzepatide cause vision problems Use of the dual GIP/GLP-1 drug (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma compared with GLP-1 drugs among patients with type 2 diabetes, a large retrospective cohort Ozempic, Wegovy & Mounjaro Vision

Aging 99 VellosoC

Dihexa vs Cerebrolysin Dihexa and Cerebrolysin both target cognitive enhancement and neuroprotection, but they occupy fundamentally different positions on the evidence spectrum

Insulin syringes are the least expensive option for insulin delivery

The presence of diabetes did not meaningfully affect these results, suggesting that these benefits were not unique to patients with diabetes. The study included 229 patients with RA and overweight or obesity (BMI 27) who were prescribed a GLP-1 RA between 2018 and 2024

Certain plans require prior authorization, which is how the insurance company confirms that a drug meets its criteria for coverage